This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

G-Spring (2016-11-04)

Starting date:
November 4, 2016
Posting date:
November 16, 2016
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-61090

Reason

The product is labelled to contain a prescription drug substance (L-Dopa).

Depth of distribution

Retailers

Affected products

G-Spring

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Capsules

Strength

Per 4 capsules (according to label):

  • Vitamin D3 (as cholecalciferol) 1000IU
  • L-Arginine Pyroglutamate 1000mg
  • L-Lysine 1000mg
  • Mucuna Pruriens (Velvet Bean) (50% L-dopa) 300mg
  • Bacopa Monnieri 30:1 Extract 220mg
  • Puerarin (Radix puerariae) 100mg
  • L-Theanine 100mg
  • DMAE Bitartrate 100mg
  • Melatonin 20mg
  • Piperine Extract (95%) 5mg

Lot or serial number

33682

Companies

Recalling Firm
Magnum Nutraceuticals
White Rock
British Columbia
CANADA
Marketing Authorization Holder
Magnum Nutraceuticals
White Rock
British Columbia
CANADA